BIO(BIO)
BIO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.58B | $2.66B | $2.74B | $2.82B | $2.90B |
| Low | $2.53B | $2.60B | $2.62B | $2.76B | $2.84B |
| High | $2.61B | $2.67B | $2.81B | $2.85B | $2.93B |
| EBITDA Avg | $-308M | $-317M | $-327M | $-336M | $-346M |
| Low | $-311M | $-318M | $-334M | $-340M | $-349M |
| High | $-302M | $-310M | $-312M | $-329M | $-338M |
| EBIT Avg | $-408M | $-420M | $-433M | $-445M | $-458M |
| Low | $-412M | $-421M | $-443M | $-450M | $-462M |
| High | $-399M | $-411M | $-414M | $-436M | $-448M |
| Net Income Avg | $263M | $282M | $304M | $338M | $382M |
| Low | $255M | $274M | $298M | $329M | $372M |
| High | $271M | $291M | $310M | $343M | $387M |
| EPS Avg | $9.64 | $10.35 | $11.23 | $12.40 | $14.01 |
| Low | $9.34 | $10.03 | $10.93 | $12.07 | $13.63 |
| High | $9.94 | $10.66 | $11.38 | $12.56 | $14.19 |
| Analysts (Rev / EPS) | 3 / 2 | 4 / 2 | 3 / 1 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $651M | $690M | $609M | $669M | $669M | $711M | $628M | $690M |
| Low | $647M | $686M | $605M | $665M | $665M | $707M | $624M | $686M |
| High | $654M | $694M | $612M | $672M | $672M | $714M | $631M | $693M |
| EBITDA Avg | $-78M | $-82M | $-73M | $-80M | $-80M | $-85M | $-75M | $-82M |
| Low | $-78M | $-83M | $-73M | $-80M | $-80M | $-85M | $-75M | $-83M |
| High | $-77M | $-82M | $-72M | $-79M | $-79M | $-84M | $-74M | $-82M |
| EBIT Avg | $-103M | $-109M | $-96M | $-106M | $-106M | $-112M | $-99M | $-109M |
| Low | $-103M | $-109M | $-97M | $-106M | $-106M | $-113M | $-100M | $-109M |
| High | $-102M | $-108M | $-95M | $-105M | $-105M | $-111M | $-98M | $-108M |
| Net Income Avg | $60M | $78M | $67M | $72M | $71M | $76M | $90M | $80M |
| Low | $59M | $77M | $66M | $71M | $71M | $75M | $89M | $79M |
| High | $60M | $78M | $67M | $72M | $72M | $76M | $90M | $80M |
| EPS Avg | $2.23 | $2.91 | $2.48 | $2.68 | $2.65 | $2.82 | $3.34 | $2.97 |
| Low | $2.21 | $2.88 | $2.46 | $2.66 | $2.63 | $2.80 | $3.32 | $2.95 |
| High | $2.25 | $2.93 | $2.50 | $2.70 | $2.67 | $2.84 | $3.37 | $2.99 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |